These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 697242)

  • 1. Carcinoembryonic antigen and monitoring of metastatic colorectal carcinoma.
    Lokich JJ
    Ann Intern Med; 1978 Oct; 89(4):573-4. PubMed ID: 697242
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinoembryonic antigen as a prognostic and monitoring test in colorectal carcinoma.
    Chatterji A; Batabyal SK
    Indian J Pathol Microbiol; 1987 Jan; 30(1):81-7. PubMed ID: 3679340
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinoembryonic antigen in the management of colorectal cancer.
    Goldenberg DM
    Acta Hepatogastroenterol (Stuttg); 1979 Feb; 26(1):1-3. PubMed ID: 425796
    [No Abstract]   [Full Text] [Related]  

  • 4. [Carcinoembryonic antigen in cancer of the rectum and colon].
    Prorokov VV; Tkacheva GA; Knysh VI; Kherkheulidze ZSh
    Klin Med (Mosk); 1983 Jul; 61(7):86-9. PubMed ID: 6632761
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum glycosyl transferases and carcinoembryonic antigen in patients with colorectal carcinoma in different stages.
    Ronquist G; Rimsten A; Blanche C; Cervén E; Hiesche C; Westman M
    Acta Chir Scand; 1982; 148(4):373-7. PubMed ID: 7136442
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is the clinical significance of CEA determination in patients with colorectal carcinoma exaggerated?].
    Wedell J; Meier zu Eissen P; Meier zu Eissen J; Blanco A; van Calker H; Koldowski P; Schlipköter HW
    Med Welt; 1981 Mar; 32(11):343-7. PubMed ID: 7219141
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma.
    Elias EG; Holyoke ED; Chu TM
    Dis Colon Rectum; 1974; 17(1):38-41. PubMed ID: 4204181
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma carcinoembryonic antigen and erythrocyte sedimentation rate in patients with colorectal carcinoma.
    Thynne GS
    Med J Aust; 1979 Jun; 1(13):592-3. PubMed ID: 492000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of carcinoembryonic antigen in the clinical management of colorectal cancer.
    Green JB; Trowbridge AA
    Surg Clin North Am; 1979 Oct; 59(5):831-9. PubMed ID: 390742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colorectal carcinoma. Diagnostic value of various biological markers in postoperative recurrences].
    Antón Aranda E; Martí Cabané J; Tiberio López G; Pérez Garciá C
    Rev Clin Esp; 1984 Jan; 172(2):69-73. PubMed ID: 6201959
    [No Abstract]   [Full Text] [Related]  

  • 11. Postoperative monitoring of CEA in the prediction of surgical outcome in colorectal cancer.
    Smith AN; Gordon A; Browning GC; Williams AE; Sturgeon CM; Seth J
    J R Coll Surg Edinb; 1985 Oct; 30(5):294-8. PubMed ID: 4078776
    [No Abstract]   [Full Text] [Related]  

  • 12. Arteriovenous carcinoembryonic antigen gradient: determination by selective angiography for localization of metastatic colorectal cancer.
    Patt YZ; Mavligit G; Chuang VP; Faltely J
    Arch Surg; 1980 Sep; 115(9):1122-4. PubMed ID: 7416960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The CEA-concentration in plasma of patients with colorectal carcinoma and polyps has been determined by radioimmunoassay (RIA, Z-gel-method)].
    Ziegenbein R; Jacobasch KH; Pilgrim G; Seifart W
    Arch Geschwulstforsch; 1980; 50(2):165-8. PubMed ID: 7436700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical case contribution on the prognostic and predictive value of CEA in patients operated on for colorectal heteroplasia].
    Alabiso O; Cena E; Martorana L; Bellizzi A; Zanini M
    Minerva Chir; 1985 Oct; 40(19):1311-4. PubMed ID: 4080203
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
    McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
    Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of an unusual isozyme of lactate dehydrogenase in the serum of cancer patients and comparison with carcinoembryonic antigen.
    Manly KF; Petrelli N; Anderson GR; Emrich LJ; Herrera L; Mittelman A
    Cancer Res; 1987 Nov; 47(22):6156-60. PubMed ID: 3664517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to management of colorectal carcinoma.
    Macdonald JS
    Hosp Pract (Off Ed); 1987 May; 22(5):185-90, 192, 197-9 passim. PubMed ID: 3106373
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical aids to cancer management.
    Cooper EH
    Recent Results Cancer Res; 1977; (62):36-8. PubMed ID: 23570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical application of radioimmunolocalization in colorectal cancer].
    Germà JR; Alvarez I; Carrió I; Estorch M; Bernà L; Martínez-Duncker C; Marcuello E; Nogueras FM
    Med Clin (Barc); 1990 Mar; 94(9):325-8. PubMed ID: 2329866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of routine serum CEA determination in postoperative control in colorectal cancer].
    Pompecki R; Winkler R
    Med Welt; 1980 Dec; 31(49):1780-3. PubMed ID: 7207116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.